{"id":2271,"date":"2021-05-11T22:48:49","date_gmt":"2021-05-11T20:48:49","guid":{"rendered":"https:\/\/www.oncology-and-cytogenetic-products.com\/?p=2271"},"modified":"2021-05-11T23:29:44","modified_gmt":"2021-05-11T21:29:44","slug":"covid-19-variante-messicana-mutazione-t478k-scoperta-unibo","status":"publish","type":"post","link":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/","title":{"rendered":"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;3.22&#8243; custom_padding=&#8221;0px|||||&#8221;][et_pb_row admin_label=&#8221;row&#8221; _builder_version=&#8221;3.25&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; custom_padding=&#8221;0px|||||&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.9.4&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>Il nostro <strong>R&amp;D Manager, Simone Di Giacomo<\/strong>, in collaborazione con il <strong>Laboratorio di Genomica Computazionale<\/strong> guidato dal <strong>prof. Federico Giorgi<\/strong> presso il <strong>Dipartimento di Farmacia e Biotecnologia<\/strong> ha scoperto una nuova <strong>mutazione a carico del virus SARS-CoV2, la T478K<\/strong>. Tale mutazione \u00e8 presente in diverse varianti e <strong>molto frequente nella variante B.1.1.519, anche definita messicana<\/strong>.<\/p>\n<p>Ecco il link allo <strong>studio pubblicato sul Journal of Medical Virology<\/strong> &#8220;<em>Preliminary report on SARS-CoV-2 Spike mutation T478K&#8221;<\/em>: <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jmv.27062\">https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jmv.27062<\/a><\/p>\n<p>Fonte: <a href=\"https:\/\/www.bolognatoday.it\/attualita\/variante-messicana-coronavirus-COVID-Unibo.html\">COVID, variante messicana scoperta all\u2019Unibo: \u201cIn Italia solo 4 casi\u201d (bolognatoday.it)<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Il nostro R&amp;D Manager, Simone Di Giacomo, in collaborazione con il Laboratorio di Genomica Computazionale guidato dal prof. Federico Giorgi presso il Dipartimento di Farmacia e Biotecnologia ha scoperto una nuova mutazione a carico del virus SARS-CoV2, la T478K. Tale mutazione \u00e8 presente in diverse varianti e molto frequente nella variante B.1.1.519, anche definita messicana. [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":2281,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"Un kit diagnostico RT-PCR grazie a cui\u00a0<strong>individuare in tempi rapidi le diverse varianti del coronavirus SARS-CoV-2<\/strong>: quella inglese, ormai prevalente, ma anche quelle sudafricana, brasiliana e nigeriana.\r\n\r\n\u201cGli studi di validazione realizzati hanno mostrato\u00a0<strong>un livello di sensibilit\u00e0 vicino al 100 per cento<\/strong>, e il kit \u00e8 utilizzabile\u00a0<strong>in ogni tipo di laboratorio<\/strong>, anche di piccole dimensioni\u201d, dice\u00a0<strong>Enrico Di Oto<\/strong>, fondatore e amministratore delegato di OaCP, che si \u00e8 specializzato in Patologia Clinica e Oncologia sperimentale all\u2019Universit\u00e0 di Bologna. \u201cIl kit \u00e8 attualmente utilizzato in Sicilia come strumento per la definizione delle varianti e stiamo lavorando per espanderne l'uso sia in altre regioni d'Italia che tra i laboratori privati accreditati per la diagnostica COVID-19\u201d.\r\n\r\n<a href=\"https:\/\/magazine.unibo.it\/archivio\/2021\/04\/15\/da-uno-spin-off-unibo-nasce-un-test-rapido-per-individuare-le-varianti-del-coronavirus\">Da uno spin-off Unibo nasce un test rapido per individuare le varianti del coronavirus \u2014 UniboMagazine<\/a>","_et_gb_content_width":"","footnotes":""},"categories":[41,45,44],"tags":[],"class_list":["post-2271","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19-insights","category-oacp","category-press"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo - OaCP<\/title>\n<meta name=\"description\" content=\"Il nostro R&amp;D Manager, Simone Di Giacomo, con il team del quale fa parte presso il Dipartimento di Farmacia e Biotecnologie dell&#039;Universit\u00e0 di Bologna ha scoperto una nuova mutazione del Covid-19, la variante messicana (mutazione T478K).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo - OaCP\" \/>\n<meta property=\"og:description\" content=\"Il nostro R&amp;D Manager, Simone Di Giacomo, con il team del quale fa parte presso il Dipartimento di Farmacia e Biotecnologie dell&#039;Universit\u00e0 di Bologna ha scoperto una nuova mutazione del Covid-19, la variante messicana (mutazione T478K).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/\" \/>\n<meta property=\"og:site_name\" content=\"OaCP\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-11T20:48:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-11T21:29:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"731\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Andrea Faviere\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Andrea Faviere\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/\"},\"author\":{\"name\":\"Andrea Faviere\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/person\/f3323e37ce648e6f8ebd51aba3e8cd08\"},\"headline\":\"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo\",\"datePublished\":\"2021-05-11T20:48:49+00:00\",\"dateModified\":\"2021-05-11T21:29:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/\"},\"wordCount\":184,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png\",\"articleSection\":[\"COVID-19 Insights\",\"OaCP\",\"Press\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/\",\"url\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/\",\"name\":\"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo - OaCP\",\"isPartOf\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png\",\"datePublished\":\"2021-05-11T20:48:49+00:00\",\"dateModified\":\"2021-05-11T21:29:44+00:00\",\"description\":\"Il nostro R&D Manager, Simone Di Giacomo, con il team del quale fa parte presso il Dipartimento di Farmacia e Biotecnologie dell'Universit\u00e0 di Bologna ha scoperto una nuova mutazione del Covid-19, la variante messicana (mutazione T478K).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage\",\"url\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png\",\"contentUrl\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png\",\"width\":1280,\"height\":731},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#website\",\"url\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/\",\"name\":\"OaCP\",\"description\":\"Oncology and Cytogenetic Products\",\"publisher\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#organization\",\"name\":\"OACP IE LTD\",\"url\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2018\/10\/logo-OaCP.png\",\"contentUrl\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2018\/10\/logo-OaCP.png\",\"width\":159,\"height\":70,\"caption\":\"OACP IE LTD\"},\"image\":{\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/person\/f3323e37ce648e6f8ebd51aba3e8cd08\",\"name\":\"Andrea Faviere\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/762e80340f20c117281bda8dc6c0fb77c59236bdfad2a5aea61701d78bf09501?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/762e80340f20c117281bda8dc6c0fb77c59236bdfad2a5aea61701d78bf09501?s=96&d=mm&r=g\",\"caption\":\"Andrea Faviere\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo - OaCP","description":"Il nostro R&D Manager, Simone Di Giacomo, con il team del quale fa parte presso il Dipartimento di Farmacia e Biotecnologie dell'Universit\u00e0 di Bologna ha scoperto una nuova mutazione del Covid-19, la variante messicana (mutazione T478K).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/","og_locale":"it_IT","og_type":"article","og_title":"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo - OaCP","og_description":"Il nostro R&D Manager, Simone Di Giacomo, con il team del quale fa parte presso il Dipartimento di Farmacia e Biotecnologie dell'Universit\u00e0 di Bologna ha scoperto una nuova mutazione del Covid-19, la variante messicana (mutazione T478K).","og_url":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/","og_site_name":"OaCP","article_published_time":"2021-05-11T20:48:49+00:00","article_modified_time":"2021-05-11T21:29:44+00:00","og_image":[{"width":1280,"height":731,"url":"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png","type":"image\/png"}],"author":"Andrea Faviere","twitter_misc":{"Scritto da":"Andrea Faviere","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#article","isPartOf":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/"},"author":{"name":"Andrea Faviere","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/person\/f3323e37ce648e6f8ebd51aba3e8cd08"},"headline":"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo","datePublished":"2021-05-11T20:48:49+00:00","dateModified":"2021-05-11T21:29:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/"},"wordCount":184,"commentCount":0,"publisher":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#organization"},"image":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png","articleSection":["COVID-19 Insights","OaCP","Press"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/","url":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/","name":"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo - OaCP","isPartOf":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage"},"image":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png","datePublished":"2021-05-11T20:48:49+00:00","dateModified":"2021-05-11T21:29:44+00:00","description":"Il nostro R&D Manager, Simone Di Giacomo, con il team del quale fa parte presso il Dipartimento di Farmacia e Biotecnologie dell'Universit\u00e0 di Bologna ha scoperto una nuova mutazione del Covid-19, la variante messicana (mutazione T478K).","breadcrumb":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#primaryimage","url":"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png","contentUrl":"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2021\/05\/T478K.png","width":1280,"height":731},{"@type":"BreadcrumbList","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/covid-19-variante-messicana-mutazione-t478k-scoperta-unibo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/"},{"@type":"ListItem","position":2,"name":"COVID-19, variante messicana (mutazione T478K) scoperta dall\u2019Unibo"}]},{"@type":"WebSite","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#website","url":"https:\/\/www.oncology-and-cytogenetic-products.com\/","name":"OaCP","description":"Oncology and Cytogenetic Products","publisher":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oncology-and-cytogenetic-products.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#organization","name":"OACP IE LTD","url":"https:\/\/www.oncology-and-cytogenetic-products.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2018\/10\/logo-OaCP.png","contentUrl":"https:\/\/www.oncology-and-cytogenetic-products.com\/wp-content\/uploads\/2018\/10\/logo-OaCP.png","width":159,"height":70,"caption":"OACP IE LTD"},"image":{"@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/person\/f3323e37ce648e6f8ebd51aba3e8cd08","name":"Andrea Faviere","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.oncology-and-cytogenetic-products.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/762e80340f20c117281bda8dc6c0fb77c59236bdfad2a5aea61701d78bf09501?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/762e80340f20c117281bda8dc6c0fb77c59236bdfad2a5aea61701d78bf09501?s=96&d=mm&r=g","caption":"Andrea Faviere"}}]}},"_links":{"self":[{"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/posts\/2271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/comments?post=2271"}],"version-history":[{"count":11,"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/posts\/2271\/revisions"}],"predecessor-version":[{"id":2299,"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/posts\/2271\/revisions\/2299"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/media\/2281"}],"wp:attachment":[{"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/media?parent=2271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/categories?post=2271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oncology-and-cytogenetic-products.com\/it\/wp-json\/wp\/v2\/tags?post=2271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}